Anavex Presents Encouraging Results of Alzheimer’s Therapy Phase 1 Trial

Anavex Presents Encouraging Results of Alzheimer’s Therapy Phase 1 Trial

clinical trialBiopharmaceutical company Anavex Life Sciences Corp. recently presented encouraging results from their phase 1 clinical trial, a study testing the company's lead investigational oral treatment for Alzheimer's disease, Anavex 2-73, at CNS Summit 2014 in Boca Raton, Flori

Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *